Gary K. Lee
LYELGary K. Lee serves as officer: Chief Scientific Officer at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Gary K. Lee's Insider Trading at Lyell Immunopharma, Inc. (LYEL)
Buys
0 · $0.00
Sells
8 · $76.5K
Total Shares Bought
0
Total Shares Sold
4,070
Related Insiders
Lynn Seely
President and CEO
LYELSell · Nov 12, 2026
Veronica Sanchez Bulis
VP, Corporate Controller
LYELSell · Nov 12, 2026
Stephen J. Hill
officer: Chief Operating Officer
LYELSell · Nov 12, 2026
ARCH Venture Fund XIII, L.P.
10 percent owner
LYELBuy · Nov 5, 2026
ARCH Venture Partners IX, LLC
10 percent owner
LYELBuy · Nov 5, 2026
Jarrad Mattieu Aguirre
officer: Chief Medical Officer
LYELSell · Oct 13, 2026
David Shook
officer: Chief Medical Officer
LYELSell · Sep 10, 2026
Innovative Cellular Therapeutics Holdings Ltd
10 percent owner
LYELSell · Jul 20, 2026